This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations. In 2022, the Advisory Committee on Immunization Practices (ACIP) published updated pneumococcal vaccine recommendations.
Garofoli, PharmD, BCACP, CTTS, FAPhA Publication Article Drug Topics Journal Drug Topics May/June 2025 Volume 169 Issue 03 Pharmacy team members can help patients prepare for upcoming travels, ensuring they are up to date with the recommended vaccines for their locations. The first resource is the CDC’s Yellow Book.
Experts discuss the recent dismissal of all 17 members of the Advisory Committee on Immunization Practices (ACIP), a panel that provides guidance to the CDC on vaccine recommendations.
Today, we’re speaking to Simone Steiner, Transgene’s new chief technology officer, about how the company is transitioning from early- to late-stage testing and advancing its manufacturing capabilities Oncology vaccines are gaining traction in the clinic as potential game changing treatments for cancer.
With significant progress made in researchers’ understanding of dermatological diseases, a pathway has been made for the development of targeted vaccines, according to data published in Vaccines. 5 Throughout the past 10 years, development of vaccines for preventing skin diseases has made significant progress.
June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. GSK has licensed altSonflex1-2-3, its Shigella vaccine candidate, to Bharat Biotech for continued development and distribution in low and middle-income nations. Credit: viewimage/Shutterstock.
The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. 1 The company said approval of the new presentation was based on data that showed comparability between the new and existing version of the vaccine.
Even things like having a technician be in charge of inventory or immunizations or patient scheduling for our comprehensive medication reviews, giving them these roles where there are opportunities for growth. I think being able to assign responsibilities that demonstrate that people have real value and real assets to their pharmacy.
In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.
Further, the incidence, severity, and kinetics of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome with CD20 × CD3 TCEs may vary depending on the B-cell lymphoma subtype and the combination partners used, which is a notable consideration for oncology pharmacists when operationalizing these therapies.
Recent Videos Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
Related Content Pharmacy Technicians Could Enhance Public Health by Becoming ‘Vaccine Champions’ Killian Meara October 3rd 2024 Article Researchers suggest that vaccine champion programs could be a promising avenue to increasing immunization rates.
November 8, 2024. August 30, 2024. ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older Ashley Gallagher April 17th 2025 Article Currently, the recommendation is for patients 75 years and older and those aged 60 to 74 years with an increased risk of severe respiratory syncytial virus. Mayo Clinic.
5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. Deaths were reported in 5 TN and 6 R/R patients. The trial enrolled 598 patients 65 years or older with TN MCL.
Updated April 2, 2024. A study of JNJ-68284528, a chimeric antigen receptor T cell (CAR-T) therapy directed against B-cell maturation antigen (BCMA) in participants with relapsed or refractory multiple myeloma (CARTITUDE-1). Accessed June 24, 2025.
Updated November 21, 2024. Vaccine Coverage Remains Low Among Forcibly Displaced Children Brian Nowosielski June 17th 2025 Article Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.
2024;(518):CS355235. Related Content Measles Outbreak Reaches Over 800 Confirmed Cases in the US Ashley Gallagher June 7th 2025 Article Building trust with patients through fact-based information could help boost vaccination rates to the desirable coverage. Sign up today for our free Drug Topics newsletter. REFERENCES 1. adults, 2023.
The FDA approved nemolizumab in December 2024 for the treatment of moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors when the disease is not controlled by topical prescription therapies among individuals 12 and older.
Since launching the service in September 2024, they’ve dispensed more than 300 boxes, with an estimated 72% acceptance rate. When patients are prescribed an opioid for the first time, the system alerts staff for a clinical consult. 1 This service can not only expand pharmacies’ clinical offerings but serves a crucial public health benefit.
CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. HOPA has selected 4.0 Additional information is available here.
2024 Global Strategy for Asthma Mnagement and Prevention Guidelines. A comprehensive evaluation of asthma therapy within a large healthcare system. Presented at: American Society of Health-System Pharmacists 2025 Pharmacy Futures. Charlotte, NC; June 9, 2025. Global Initiative for Asthma. Accessed June 9, 2025.
This phase 1b clinical trial, conducted between September 2023 and November 2024, was designed to build on promising preclinical data that demonstrated improved efficacy and tolerability with continuous SC lenalidomide delivery in murine MM models.
Updated November 14, 2024. Lastly, pharmacists should consider offering mail-back envelopes at no charge to provide patients with a convenient and secure alternative to other disposal options. REFERENCES 1. The impact of pharmaceuticals released to the environment. United States Environmental Protection Agency. Accessed June 6, 2025.
Updated April 10, 2024. link] articles/2018/12/dysmenorrhea-and-endometriosis-in-the-adolescent 4. Smith RP, Kaunitz AM. Dysmenorrhea in adult females: clinical features and diagnosis. Accessed April 28, 2025. Balik G, Ustüner I, Kağitci M, Sahin FK. Is there a relationship between mood disorders and dysmenorrhea? J Pediatr Adolesc Gynecol.
Updated September 10, 2024. TOC services are one of many areas where pharmacy models can improve patient outcomes, quality metrics, and hospital revenue. 4-6 Since this study’s completion, the institution has expanded its protocol with additional prescribing opportunities for TOC pharmacists and plans to expand services to non-HRRP patients.
Successful RCM implementation can help pharmacies recover significant funds, with Outcomes reporting nearly $3 million recovered for clients in 2024 and 2025. Polek recommends pharmacies carefully select RCM partners who offer comprehensive services, quick claim reconciliation, and robust reporting capabilities.
2024 ESC guidelines for the management of elevated blood pressure and hypertension. J Am Coll Cardiol. 2018;71:e127-e248. doi:10.1016/j.jacc.2017.11.006 2017.11.006 Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021–3104. Eur Heart J.
September 11, 2024. Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study. News release. Accessed June 18, 2025.
1 The current post hoc secondary analysis was conducted from March to June 2024 and aimed to further evaluate the spillover of an audit-and-feedback intervention that targets individuals aged 65 and older on a broader population of all age groups.
FDA approvals dropped in May to 14 drugs after hitting 20 and above in the two months prior, but the total of 84 OKs so far in 2025 is the second only to 2024’s record high for the first part of the year, according to Clarivate. A long-time leader in vaccines, the U.K.
Receiving CAR T therapy can take several weeks, and though very effective against difficult-to-treat cancers, it can sometimes cause life-threatening adverse events, such as cytokine release syndrome (CRS) or immune effector cell-associated neurotoxicity syndrome (ICANS).
October 19, 2024. December 2024. Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial. The Lancet. doi: 10.1016/S0140-6736(24)01744-6 5.
Records from patients who received oncology treatment from Walgreens Specialty Pharmacy from December 2023 to October 2024 were analyzed to determine the percentage of patients who opted for a fertility preservation counseling session. Materials and Methods This study design was descriptive, nonexperimental, and retrospective.
CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. HOPA has selected 4.0 Additional information is available here.
Updated June 20, 2024. This direct engagement is crucial in building confidence in biosimilars and ensuring their appropriate utilization, contributing to more affordable and accessible health care. REFERENCES 1. Nine things to know about biosimilars and interchangeable biosimilars. Accessed May 13, 2025. Biosimilar medicines: overview.
This single-center, retrospective, observational study included data from electronic health records and specialty pharmacies from January 1, 2023, to June 1, 2024, with specialty pharmacy dispensing data specifically used to identify patients who had received Humira and a biosimilar during the study period.
Immune effector cell–associated neurotoxicity syndrome was less common but observed in 28% (grade ≥3, 5%). months progression-free survival in real-world RRMM patients, consistent with KarMMa trial results. months progression-free survival in real-world RRMM patients, consistent with KarMMa trial results.
September 11, 2024. Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study. News release. Accessed June 18, 2025.
Community-acquired pneumonia (CAP) is a common infection caused by the inhalation of various organisms into the lower respiratory tract, which can ultimately initiate an immune and inflammatory response, potentially leading to damage to lung parenchyma.
Updated November 13, 2024. link] eptinezumab-jjmr -the-first-a New data demonstrates robust efficacy of Eptinezumab-jjmr® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine. News release. PR Newswire. June 21, 2025. Accessed July 2, 2025. link] Aetna. Clinical Policy Bulletin 0970: Eptinezumab‑jjmr (Eptinezumab-jjmr).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content